Raptor Pharmaceuticals Inc.
Records under this name other than patents Raptor Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Raptor Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,524,734 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,524,735 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,546,423 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,838,532 | Aerosolized fluoroquinolones and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,717,738 | Aerosol fluoroquinolone formulations for improved pharmacokinetics Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,722,519 | Aerosol fluoroquinolone formulations for improved pharmacokinetics Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,020,481 | Topical use of levofloxacin for reducing lung inflammation Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,326,936 | Aerosol fluoroquinolone formulations for improved pharmacokinetics Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,629,139 | Topical use of Levofloxacin for reducing lung inflammation Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,700,564 | Use of aerosolized levofloxacin for treating cystic fibrosis Formerly held In force · USPTO record | In force | USPTO record |